Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

BACKGROUND: Individuals with diabetes often have high levels of atherogenic lipoproteins and cholesterol reflected by elevated low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), apolipoprotein B (ApoB), and LDL particle number (LDL-PN). The presence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Kausik K., Del Prato, Stefano, Müller-Wieland, Dirk, Cariou, Bertrand, Colhoun, Helen M., Tinahones, Francisco J., Domenger, Catherine, Letierce, Alexia, Mandel, Jonas, Samuel, Rita, Bujas-Bobanovic, Maja, Leiter, Lawrence A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842201/
https://www.ncbi.nlm.nih.gov/pubmed/31706300
http://dx.doi.org/10.1186/s12933-019-0951-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842201/
https://www.ncbi.nlm.nih.gov/pubmed/31706300
http://dx.doi.org/10.1186/s12933-019-0951-9

Ejemplares similares